- Report
- November 2023
- 150 Pages
Global
From €4683EUR$4,850USD£3,965GBP
- Report
- November 2023
- 150 Pages
Global
From €4683EUR$4,850USD£3,965GBP
- Report
- October 2023
- 150 Pages
Global
From €4683EUR$4,850USD£3,965GBP
- Report
- October 2023
- 150 Pages
Global
From €4683EUR$4,850USD£3,965GBP
- Report
- October 2023
- 150 Pages
Global
From €4683EUR$4,850USD£3,965GBP
- Report
- May 2024
- 180 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- May 2024
- 185 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- May 2024
- 180 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- April 2024
- 180 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- February 2024
- 175 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- February 2024
- 187 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- February 2024
- 185 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- February 2024
- 184 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- November 2023
- 190 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- November 2023
- 190 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- November 2023
- 180 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- November 2023
- 190 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- October 2023
- 183 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- October 2023
- 177 Pages
Global
From €4731EUR$4,900USD£4,006GBP
- Report
- October 2023
- 178 Pages
Global
From €4731EUR$4,900USD£4,006GBP
The RNA market is a subset of the genomics market that focuses on the study of ribonucleic acid (RNA). RNA is a molecule that plays a key role in the regulation of gene expression and is involved in many cellular processes. It is used in a variety of applications, including diagnostics, therapeutics, and research.
The RNA market is expected to grow at a steady rate due to the increasing demand for RNA-based products and services. This growth is driven by advances in technology, such as next-generation sequencing, which has enabled the development of more accurate and cost-effective RNA-based products. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine are expected to drive the growth of the RNA market.
Companies in the RNA market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, Bio-Rad Laboratories, and F. Hoffmann-La Roche. Show Less Read more